As of December 2024 Edwards Lifesciences has a market cap of S$58.46 Billion. This makes Edwards Lifesciences the world's 457th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2024 | S$58.46 B | -4.27% |
2023 | S$61.07 B | -1.23% |
2022 | S$61.83 B | -43.45% |
2021 | S$109.34 B | 45.37% |
2020 | S$75.22 B | 14.38% |
2019 | S$65.76 B | 51.32% |
2018 | S$43.46 B | 36.24% |
2017 | S$31.90 B | 10.02% |
2016 | S$28.99 B | 20.49% |
2015 | S$24.06 B | 32.63% |
2014 | S$18.14 B | 99.24% |
2013 | S$9.10 B | -27.75% |
2012 | S$12.60 B | 20.67% |
2011 | S$10.44 B | -12.78% |
2010 | S$11.97 B | 72.91% |
2009 | S$6.92 B | 58.33% |
2008 | S$4.37 B | 16.78% |
2007 | S$3.74 B | -10% |
2006 | S$4.16 B | 0.92% |
2005 | S$4.12 B | 3.08% |
2004 | S$4.00 B | 31.62% |
2003 | S$3.03 B | 14.3% |
2002 | S$2.65 B | -12.36% |
2001 | S$3.03 B | 68.08% |
2000 | S$1.80 B |
On Dec 18th, 2024 the market cap of Edwards Lifesciences was reported to be: